Helsana HealthInvest
Overview
Helsana HealthInvest AG is the corporate venture capital subsidiary of the Swiss health insurance provider Helsana. Founded in 2020 and operational since 2021, it invests in European startups and venture funds focused on digital health. The firm's goal is to improve efficiency and care in the Swiss healthcare system. Its investment focus is on Series A to B companies in the DACH, Benelux, and Nordic regions. While the primary focus is digital health, it may also invest in fintech, insurtech, or cybersecurity, but explicitly excludes biotechnology, life sciences, and pharma. The evergreen fund has a volume of CHF 100 million.
Portfolio Companies
2
Website
helsana.chInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hedera Dx | May 2025 | Series A | Co-investor |
| Yazen Health | Nov 2024 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Helsana HealthInvest based?
Helsana HealthInvest is headquartered in Dübendorf, Zürich, Switzerland.
When was Helsana HealthInvest founded?
Founding year information for Helsana HealthInvest is not publicly available.
How many portfolio companies does Helsana HealthInvest have?
Helsana HealthInvest has 2 portfolio companies in Caplight's dataset.
What are some companies in Helsana HealthInvest's portfolio?
Portfolio companies visible on Caplight include Hedera Dx, Yazen Health.
What was Helsana HealthInvest's most recent investment shown here?
Helsana HealthInvest's most recent investment in this portfolio sample was in Hedera Dx in 2025.
What sectors does Helsana HealthInvest focus on?
Helsana HealthInvest focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Consumer & Commerce.
What company stages does Helsana HealthInvest focus on?
Helsana HealthInvest typically invests at the Early stage.
What is Helsana HealthInvest's AUM?
Helsana HealthInvest's assets under management are estimated between $112.0M and $112.0M.